| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/12/2001 | WO2001049260A2 Y-ifn liquid-droplet aerosol and method |
| 07/12/2001 | WO2001049252A2 Oil-in-water type cosmetic or dermatological preparations |
| 07/12/2001 | WO2001049249A2 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 07/12/2001 | WO2001003669A3 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 07/12/2001 | WO2001000549A3 Branched largely insatured fatty alcohols |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | WO2000041528A9 Improved controlled release compositions and method |
| 07/12/2001 | WO2000032205A9 Immunomodulatory methods using carbohydrate antigens |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007866 Treatment of pruritus with vitamin d and analogs thereof |
| 07/12/2001 | US20010007862 Aqueous solution of cyclodextrin |
| 07/12/2001 | US20010007858 Stable mixture |
| 07/12/2001 | US20010007771 Cationic polymers and lipids for the delivery of nucleic acids |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007765 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007754 Isolation an antimicrobial agent; complexing with genetic engineered b-lactamase inhibitor; detection; calibration |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | US20010007678 Melt extrusion mixture containing itraconazole |
| 07/12/2001 | US20010007673 Sustained-release delayed gels |
| 07/12/2001 | US20010007670 Novel formulations comprising lipid-regulating agents |
| 07/12/2001 | US20010007666 Destroying endosomal membrane in response to low pH |
| 07/12/2001 | US20010007665 Respiratory system |
| 07/12/2001 | US20010007663 Microemulsions for use as vehicles for administration of active compounds |
| 07/12/2001 | US20010007662 Aqueous formulation suitable for lyophilization; biologically active form of nerve growth factor with bulking agent, buffer and water |
| 07/12/2001 | US20010007658 Medium and matrix for long-term proliferation of cells |
| 07/12/2001 | US20010007651 Masking and eliminating odors; preservative, counterirritant, solubility enhancer, antiseptic, fungicide, microbiocide, anti-infective, healing agent; smoker's-breath; placebo |
| 07/12/2001 | DE19964085A1 Particulate solid drug carrier, providing retarded release and high bioavailability, comprising lipid-drug conjugate, e.g. tributyrin as source of cell differentiation inhibitor butyric acid |
| 07/12/2001 | DE19962470A1 Verwendung von Chemotherapeutika Use of chemotherapeutic agents |
| 07/12/2001 | DE19962427A1 Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung Multifunctional encapsulated biologically active food component, process for their preparation and their use |
| 07/12/2001 | DE19952073A1 Verfahren zur Herstellung von nanopartikulären Chitosanen oder Chitosan-Derivaten Process for preparing nanoparticulate chitosans or chitosan derivatives |
| 07/12/2001 | DE10061801A1 New compositions containing hydrophilic film former, water and urea useful for non-traumatic removal of fungally infected areas in finger- and toenails |
| 07/12/2001 | DE10001682A1 Preparation comprising separate carrier material and solvent for the formation of particles or implants by admixture shortly before use and dispersion in an outer phase |
| 07/12/2001 | DE10000648A1 New crosslinked copolymers containing vinyl lactam and N-(sulfoalkyl)-acrylamide salt repeating units, especially useful as thickeners in cosmetic or pharmaceutical compositions |
| 07/12/2001 | DE10000210A1 Stable oil-in-water preparations which include a citrate ester, are useful, e.g., in care of skin and are stabilized by a very low density difference between the oil and aqueous phases |
| 07/12/2001 | CA2397714A1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | CA2396379A1 Pharmaceutical compositions for oral administration |
| 07/12/2001 | CA2396037A1 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395887A1 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | CA2395803A1 Y-ifn liquid-droplet aerosol and method |
| 07/12/2001 | CA2395742A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | CA2395132A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | CA2394297A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | CA2393942A1 Odor-masking coating for a pharmaceutical preparation |
| 07/11/2001 | EP1114644A1 Composition comprising NPH insulin (neutral protamine hagedorn insulin) |
| 07/11/2001 | EP1114641A2 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 07/11/2001 | EP1114144A1 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent |
| 07/11/2001 | EP1113827A1 Polymer immobilized living cells and applications thereof |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113819A2 Antibody directed enzyme prodrug therapy (adept) with glucuronidase |
| 07/11/2001 | EP1113799A1 Protein formulations |
| 07/11/2001 | EP1113798A1 Topical formulation of alkyl-, phenyl-pyridone |
| 07/11/2001 | EP1113788A2 Transdermal devices comprising essential oils for aromatherapy |
| 07/11/2001 | EP1113787A1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same |
| 07/11/2001 | EP1113786A1 New pharmaceutical formulation |
| 07/11/2001 | EP1113785A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 07/11/2001 | EP0927037B1 Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 07/11/2001 | EP0758231B1 Taxane class derivative based pharmaceutical compositions |
| 07/11/2001 | EP0752847B1 Ophthalmic composition with decreased viscosity |
| 07/11/2001 | EP0735876B1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin |
| 07/11/2001 | EP0679398B1 Immunopotentiating and infection protective agent and production thereof |
| 07/11/2001 | EP0659080B1 Method for the treatment of hair loss |
| 07/11/2001 | EP0658112B1 A conjugate comprising a straight-chained polymer having bound sulphated glucosaminoglucans such as heparin, its preparation, use and a corresponding substrate |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303297A Treatment of arthritis and other similar conditions |
| 07/11/2001 | CN1303291A Sustained-release composition containing cefaclor |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303284A 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 07/11/2001 | CN1303280A Stable dosage forms of fluoxetine and its enantiomers |
| 07/11/2001 | CN1303278A Compositions containing microparticles of water-insoluble substances and method for their preparation |
| 07/11/2001 | CN1303275A Polymer based rapidly dissolving tablets and production processes thereof |
| 07/11/2001 | CN1303274A Novel poly (methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 07/11/2001 | CN1303269A Anticancer compositions |
| 07/11/2001 | CN1303263A Topital delivery system for active agents |
| 07/11/2001 | CN1303260A Alpha-hydroxy fatty acid derivatives and composition for external use containing same |
| 07/11/2001 | CN1302663A Substrate tablet containing trimetazidine capable of long time controlled release after oral application |
| 07/11/2001 | CN1302608A Clonidine preparation |
| 07/11/2001 | CN1302605A Controlled releasing oral medicine composition |
| 07/11/2001 | CN1302604A Controlled release composition |
| 07/11/2001 | CN1068227C Interferon liposome jellies |
| 07/11/2001 | CN1068199C Anti-cancer microballs and manufacturing method thereof |
| 07/11/2001 | CN1068198C Production method of composite preparation of bone morphogenesis protein and collagen particle |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | WO2001051056A1 Fulvestrant formulation |
| 07/10/2001 | US6258995 Wound treatment composition |
| 07/10/2001 | US6258870 Gels for encapsulation of biological materials |
| 07/10/2001 | US6258836 Dopamine analog amide |
| 07/10/2001 | US6258831 Viral treatment |
| 07/10/2001 | US6258830 Skin disorders, psoriasis and acne |
| 07/10/2001 | US6258821 Compositions comprising trimetrexate and methods of their synthesis and use |
| 07/10/2001 | US6258816 Anti-allergy anti-inflammatory composition |
| 07/10/2001 | US6258808 Pharmaceutical composition |
| 07/10/2001 | US6258799 Hydroxypropylmethyl cellulose trimelliate and plasticizers |
| 07/10/2001 | US6258796 Lipophilic, water soluble compounds to treat diseases |
| 07/10/2001 | US6258782 Hybrid polypeptides with enhanced pharmacokinetic properties |